During the recent session, Petros Pharmaceuticals Inc (NASDAQ:PTPI)’s traded shares were 39.62 million, with the beta value of the company hitting 1.77. At the last check today, the stock’s price was $0.12, reflecting an intraday loss of -9.26% or -$0.02. The 52-week high for the PTPI share is $1.52, that puts it down -1166.67 from that peak though still a striking 58.33% gain since the share price plummeted to a 52-week low of $0.05. The company’s market capitalization is $3.67M, and the average intraday trading volume over the past 10 days was 165.93 million shares, and the average trade volume was 34.01 million shares over the past three months.
Petros Pharmaceuticals Inc (NASDAQ:PTPI) trade information
Petros Pharmaceuticals Inc (PTPI) registered a -9.26% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -9.26% in intraday trading to $0.12, hitting a weekly high. The stock’s 5-day price performance is 61.18%, and it has moved by 17.00% in 30 days. Based on these gigs, the overall price performance for the year is -92.20%. The short interest in Petros Pharmaceuticals Inc (NASDAQ:PTPI) is 0.75 million shares and it means that shorts have 0.04 day(s) to cover.
PTPI Dividends
Petros Pharmaceuticals Inc is due to release its next quarterly earnings on 2024-Nov-12. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Petros Pharmaceuticals Inc (NASDAQ:PTPI)’s Major holders
Petros Pharmaceuticals Inc insiders own 5.75% of total outstanding shares while institutional holders control 8.68%, with the float percentage being 9.21%.
Also, the Mutual Funds coming in first place with the largest holdings of Petros Pharmaceuticals Inc (PTPI) shares are Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund. Data provided on Dec 31, 2024 indicates that Fidelity Concord Street Trust-Fidelity Extended Market Index Fund owns about 35.02 shares. This amounts to just over 0.12 percent of the company’s overall shares, with a $4041.0 market value. The same data shows that the other fund manager holds slightly less at 31.81, or about 0.11% of the stock, which is worth about $3670.0.
